0.200
0.000
(0.00%)
May 13 - Close
CVE
data delayed by 15 mins -
Disclaimer
Currency in CAD
| Range | - |
| 52 week | 0.05 - 0.25 |
| Open | - |
| Vol / Avg. | 0.00/31,610.00 |
| Mkt cap | 2.10M |
| P/E | - |
| Div/yield | - |
| EPS | -0.04 |
| Shares | 10.49M |
| Beta | 0.32 |
| Inst. own | - |
Key stats and ratios
| Q4 (Oct '12) | 2012 | |
| Net profit margin | - | - |
| Operating margin | - | - |
| EBITD margin | - | - |
| Return on average assets | -43.30% | -34.04% |
| Return on average equity | -95.42% | -74.66% |
| Carbon Disclosure Rating | - | - |
Address
65 Watts Avenue
CHARLOTTETOWN, PE C1E 2B7
Canada
+1-902-8927170 (Phone)
+1-902-8924426 (Fax)
CHARLOTTETOWN, PE C1E 2B7
Canada
+1-902-8927170 (Phone)
+1-902-8924426 (Fax)
Website links
External links
Discussion Group - Google Finance
Advertisement
Description
Solarvest BioEnergy Inc. is engaged in the research and development of alternative energy and nutritional oils. The Company�s bio-energy production system utilizes light and carbon dioxide to produce hydrogen leaving a clean positive environmental footprint. The Company is focused towards the development of sustainable and renewable energy sources. The Company�s technology can provide a controlled method for turning on and off genes in algae resulting in the continuous production of hydrogen gas. The Company has three wholly owned subsidiaries, which include Phycobiologics (Europe) Limited (Phyco Europe), Phyco Hydrogen Inc. (PHI), and Solarvest (P.E.I.) Inc. (PEI). In January 2013, the Company acquired 30,000 sq. ft. facility in Summerville Prince Edward Island.
Officers and directors
| Kenneth A. Cawkell | Chairman of the Board | |
| Gerri J. Greenham | President, Chief Executive Officer, Director | |
| Joseph Heng | Chief Financial Officer | |
| William M. Cheliak | Independent Director | |
| Mark S. Ledwell | Independent Director | |
| Michael L. O'Brien | Independent Director |